注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Aethlon Medical Inc(Aethlon)是一家生物技術公司。該公司專注於開發診斷和治療生命和器官威脅疾病的產品。它參與開發血液純化器,一種用於傳染病和癌症的治療性血液過濾系統。該公司通過兩個部門運營:Aethlon和ESI。Aethlon部門代表其治療業務活動。ESI部門代表其診斷業務。在癌症中,Hemopurifier被設計用來消除迴圈腫瘤來源的外泌體,這些外泌體會促進免疫抑制,播下轉移擴散的種子。該公司正在對晚期和轉移性頭頸部癌症患者進行臨床試驗。它專注於用檢查點抑制劑治療實體腫瘤的治療。血液純化劑已被用於治療感染人類免疫缺陷病毒(HIV)、丙型肝炎病毒(HCV)和埃博拉病毒的個人。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Edward G. Broenniman | 86 | 1999 | Independent Chairman of the Board |
Geert Schmid-Schönbein | - | - | Member of Sepsis & Inflammation Advisory Board |
Stephen Z. Fadem | - | - | Member of Extracorporeal Therapy Advisory Board |
Nicolas Gikakis | 57 | 2023 | Independent Director |
Nathan W. Levin | - | - | Member of Extracorporeal Therapy Advisory Board |
Larry D. Cowgill | - | - | Member of Sepsis & Inflammation Advisory Board |
Gregory T. A. Kovacs | - | - | Member of Extracorporeal Therapy Advisory Board |
Irshad H. Chaudry | - | - | Member of Sepsis & Inflammation Advisory Board |
David M. Ward | - | - | Member of Extracorporeal Therapy Advisory Board |
Claudio Ronco | - | - | Member of Extracorporeal Therapy Advisory Board |
John A. Kellum | - | - | Member of Extracorporeal Therapy Advisory Board |
Chetan S. Shah | 54 | 2013 | Independent Director |
Angela Rossetti | 70 | 2022 | Independent Director |
Charles J. Fisher | 76 | 2017 | Member of Extracorporeal Therapy Advisory Board |
James B. Frakes | 67 | 2008 | Interim CEO, CFO, Secretary & Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核